Revolutionary Urine-Based Dengue Testing Emerges from NTU Singapore
Researchers at Nanyang Technological University's Lee Kong Chian School of Medicine (LKCMedicine) have made a groundbreaking discovery that could transform how dengue fever is diagnosed and managed. By analyzing proteins present in urine, scientists can not only confirm dengue infection but also predict the likely severity of the disease. This non-invasive approach promises to empower patients, alleviate pressure on healthcare systems, and enable earlier interventions, particularly in regions where dengue remains a persistent threat.
Dengue fever, caused by the dengue virus (DENV)—a flavivirus transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes—affects millions worldwide each year. In Singapore, a tropical city-state where the disease is endemic, vigilant surveillance and rapid response are crucial. This study highlights the pivotal role of university-led research in addressing public health challenges through innovative diagnostics.
The Science Behind the Discovery: Key Researchers and Institutions
Leading the charge is Dr. Andrew Teo, a Dean's Postdoctoral Fellow at LKCMedicine, NTU Singapore, alongside Dr. Po Ying Chia, Head of the Research Office at the National Centre for Infectious Diseases (NCID) and an assistant professor at LKCMedicine. Their collaborative effort, involving 125 dengue patients in Singapore, was published in the peer-reviewed journal Open Forum Infectious Diseases on January 9, 2026.
LKCMedicine, a joint medical school between NTU and Imperial College London, exemplifies Singapore's commitment to cutting-edge biomedical research. Such institutions foster interdisciplinary teams that bridge clinical practice and academic inquiry, producing tools with real-world impact. For aspiring researchers, programs like postdoctoral fellowships at NTU offer hands-on experience in infectious disease pathogenesis and immunity.
Understanding Dengue: Background and Singapore Context
Dengue manifests in phases: febrile (high fever, headache, muscle pain), critical (potential plasma leakage leading to shock), and recovery. Severe dengue, previously known as dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS), involves complications like organ impairment and hemorrhage, with mortality rates up to 20% without prompt care.
In Singapore, the National Environment Agency (NEA) reports 4,036 cases in 2025—a 70% decline from 13,651 in 2024—thanks to robust vector control. However, January 2026 saw 149 cases, signaling potential resurgence as new serotypes emerge. Globally, the European Centre for Disease Prevention and Control notes a drop from 14 million cases in 2024 to 5 million in 2025, yet climate change expands Aedes habitats, heightening risks.
Current diagnostics rely on blood tests for non-structural protein 1 (NS1) antigen or viral RNA, which require lab processing and frequent clinic visits, burdensome during outbreaks.
Key Proteins Identified: NS1, NGAL, and suPAR Explained
The study pinpoints three urine proteins as game-changers:
- NS1 (Non-Structural Protein 1): A soluble viral protein secreted early in infection (days 1-4). Detectable in urine, it confirms dengue presence without blood draws.
- NGAL (Neutrophil Gelatinase-Associated Lipocalin): Released by neutrophils during inflammation. Elevated levels in severe cases signal kidney stress and immune overactivation.
- suPAR (Soluble Urokinase Plasminogen Activator Receptor): A marker of systemic inflammation and endothelial dysfunction. Higher concentrations correlate with progression to severe dengue.
These biomarkers differ in concentration based on severity: low in mild cases, spiking in severe ones. Step-by-step: Urine is collected, proteins quantified via assays (e.g., ELISA), and ratios compared to thresholds for prognosis.
Study Methodology: Rigorous Analysis of Real-World Samples
Over 125 confirmed dengue patients provided urine samples during the febrile phase. Researchers used proteomics—mass spectrometry-based protein identification—to profile biomarkers. Concentrations were correlated with clinical outcomes: mild vs. severe (defined by WHO criteria: plasma leakage, thrombocytopenia <100,000/mm³, etc.).
Statistical models showed high predictive accuracy, distinguishing severe cases early. This prospective design ensures reliability, building on prior blood-based studies.
Validation is underway with Sri Lanka's University of Sri Jayewardenepura, underscoring international academic collaboration.
Healthcare Implications: Reducing Burden and Empowering Patients
Dr. Teo notes: "These biomarkers can determine dengue presence and predict severity, guiding whether hospital admission is needed." This could cut unnecessary visits, easing Singapore's system amid rising cases.
Dr. Chia adds: "Patients face stress from daily clinic trips; home tests let them monitor independently." Ideal for rural Asia, where labs are scarce.Straits Times coverage
Complementing vector control (e.g., NEA's Gravitraps), it forms a two-pronged strategy.
Future Outlook: Home Test Kits on the Horizon
Researchers envision lateral flow assays—like COVID rapid tests—detecting these proteins within five years. Users dip a strip in urine, read results in minutes: positive/negative, low/high risk.
This aligns with Singapore's Smart Nation initiative, integrating AI for risk scoring. Globally, it could curb epidemics in endemic zones (Southeast Asia, Latin America).
NTU's Leadership in Infectious Disease Research
LKCMedicine's focus on translational research positions NTU as a hub for tropical medicine. Past contributions include Wolbachia trials reducing cases 77% in trial sites. Facilities like the NTU Institute for Infectious Diseases support such work.
For academics, Singapore universities offer competitive research assistant jobs and postdoc positions, with grants from A*STAR and NMRC.
Career Opportunities in Biomedical Research at Singapore Universities
This study exemplifies paths for PhDs in immunology, virology, or proteomics. Roles span lecturer positions at NTU to clinical research coordinators at NCID-affiliated hospitals.
Explore Singapore higher ed jobs, including faculty openings and career advice. Platforms like AcademicJobs.com list university jobs in infectious diseases, fostering innovation like this dengue breakthrough.
- Postdoctoral Fellowships: Hands-on biomarker discovery.
- Research Associates: Lab-based proteomics.
- Lecturers: Teaching tropical medicine modules.
Global Trends and University Contributions to Dengue Control
Universities worldwide drive dengue R&D: Duke-NUS on vaccines, Oxford on genomics. Singapore's edge: Public-private synergies (e.g., NTU-A*STAR).
Challenges persist: Serotype cross-immunity risks severe secondary infections. Solutions: Multi-biomarker panels, AI prognostics.Original study publication
Stakeholder Perspectives and Real-World Impact
Patients gain autonomy; clinicians prioritize severe cases. Policymakers can scale kits via NEA. Economically, Singapore loses S$20-50 million yearly to dengue; early detection saves costs.
Case example: During 2024's peak, overwhelmed clinics could have benefited from urine triage.
Explore related postdoc career advice or rate professors in biomedical fields.
Photo by Angelyn Sanjorjo on Unsplash
Conclusion: Pioneering Health Through Academic Innovation
NTU's urine protein discovery heralds a new era in dengue management, blending university research with practical solutions. As Singapore universities lead, opportunities abound for researchers to contribute. Visit higher ed jobs, Rate My Professor, higher ed career advice, and university jobs to join this vital field. Together, academia drives healthier futures.